Browsing Tag
AUSTEDO
2 posts
Teva gets Priority Review for ecopipam just months after buying Emalex for $700m
Teva has secured FDA Priority Review for ecopipam in pediatric Tourette syndrome, putting a late first-quarter 2027 decision date on the key asset acquired through its $700 million purchase of Emalex Biosciences.
Teva Pharmaceutical gets FDA approval for AUSTEDO XR for TD and HD
Teva Pharmaceutical Industries said that its US affiliate Teva Pharmaceuticals has secured approval for AUSTEDO XR (deutetrabenazine) extended-release…